Literature DB >> 28337319

Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization.

Elisa Nuti1, Lea Rosalia1, Doretta Cuffaro1, Caterina Camodeca1, Chiara Giacomelli1, Eleonora Da Pozzo1, Tiziano Tuccinardi1, Barbara Costa1, Claudia Antoni2, Laura Vera3, Lidia Ciccone1, Elisabetta Orlandini1, Susanna Nencetti1, Vincent Dive3, Claudia Martini1, Enrico A Stura3, Armando Rossello1.   

Abstract

Protein homodimers play important roles in physiological and pathological processes, including cancer invasion and metastasis. Recently, MMP-9 natural homodimerization via the PEX domain has been correlated with high migration rates of aggressive cancer cells. Here we propose that bifunctional MMP-9 inhibitors designed to impair natural MMP-9 homodimerization promoted by PEX-PEX interactions might be an effective tool to fight cancer cell invasion. Elaborating a previously described dimeric hydroxamate inhibitor 1, new ligands were synthesized with different linker lengths and branch points. Evaluation of the modified bifunctional ligands by X-ray crystallography and biological assays showed that 7 and 8 could reduce invasion in three glioma cell lines expressing MMP-9 at different levels. To rationalize these results, we present a theoretical model of full-length MMP-9 in complex with 7. This pioneering study suggests that a new approach using MMP-9 selective bifunctional inhibitors might lead to an effective therapy to reduce cancer cell invasion.

Entities:  

Keywords:  Bifunctional inhibitors; MMP-9 homodimerization; X-ray crystallography; glioblastoma multiforme

Year:  2017        PMID: 28337319      PMCID: PMC5346986          DOI: 10.1021/acsmedchemlett.6b00446

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  22 in total

Review 1.  Matrix metalloproteinases.

Authors:  H Nagase; J F Woessner
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

2.  Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.

Authors:  Daniel P Becker; Thomas E Barta; Louis J Bedell; Terri L Boehm; Brian R Bond; Jeffery Carroll; Chris P Carron; Gary A Decrescenzo; Alan M Easton; John N Freskos; Chris L Funckes-Shippy; Marcia Heron; Susan Hockerman; Carol Pearcy Howard; James R Kiefer; Madeleine H Li; Karl J Mathis; Joseph J McDonald; Pramod P Mehta; Grace E Munie; Teresa Sunyer; Craig A Swearingen; Clara I Villamil; Dean Welsch; Jennifer M Williams; Ying Yu; Jun Yao
Journal:  J Med Chem       Date:  2010-09-23       Impact factor: 7.446

3.  A new development of matrix metalloproteinase inhibitors: twin hydroxamic acids as potent inhibitors of MMPs.

Authors:  Armando Rossello; Elisa Nuti; Maria Pia Catalani; Paolo Carelli; Elisabetta Orlandini; Simona Rapposelli; Tiziano Tuccinardi; Susan J Atkinson; Gillian Murphy; Aldo Balsamo
Journal:  Bioorg Med Chem Lett       Date:  2005-05-02       Impact factor: 2.823

4.  The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.

Authors:  Yusheng Xiong; Judyann Wiltsie; Andrea Woods; Jian Guo; James V Pivnichny; Wei Tang; Alka Bansal; Richard T Cummings; Barry R Cunningham; Arthur M Friedlander; Cameron M Douglas; Scott P Salowe; Dennis M Zaller; Edward M Scolnick; Dennis M Schmatz; Kenneth Bartizal; Jeffrey D Hermes; Malcolm MacCoss; Kevin T Chapman
Journal:  Bioorg Med Chem Lett       Date:  2005-12-09       Impact factor: 2.823

5.  Sugar-Based Arylsulfonamide Carboxylates as Selective and Water-Soluble Matrix Metalloproteinase-12 Inhibitors.

Authors:  Elisa Nuti; Doretta Cuffaro; Felicia D'Andrea; Lea Rosalia; Livia Tepshi; Marina Fabbi; Grazia Carbotti; Silvano Ferrini; Salvatore Santamaria; Caterina Camodeca; Lidia Ciccone; Elisabetta Orlandini; Susanna Nencetti; Enrico A Stura; Vincent Dive; Armando Rossello
Journal:  ChemMedChem       Date:  2016-06-30       Impact factor: 3.466

Review 6.  Matrix metalloproteinases and tumor metastasis.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

Review 7.  Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.

Authors:  Jennifer Vandooren; Philippe E Van den Steen; Ghislain Opdenakker
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-04-02       Impact factor: 8.250

8.  MMP inhibition by barbiturate homodimers.

Authors:  Jun Wang; Marek W Radomski; Carlos Medina; John F Gilmer
Journal:  Bioorg Med Chem Lett       Date:  2012-11-29       Impact factor: 2.823

9.  Comparative expression pattern of Matrix-Metalloproteinases in human glioblastoma cell-lines and primary cultures.

Authors:  Carsten Hagemann; Jelena Anacker; Stefanie Haas; Daniela Riesner; Beate Schömig; Ralf-Ingo Ernestus; Giles H Vince
Journal:  BMC Res Notes       Date:  2010-11-10

10.  Role of the hemopexin domain of matrix metalloproteinases in cell migration.

Authors:  Antoine Dufour; Nicole S Sampson; Stanley Zucker; Jian Cao
Journal:  J Cell Physiol       Date:  2008-12       Impact factor: 6.384

View more
  4 in total

Review 1.  Multidimensional communication in the microenvirons of glioblastoma.

Authors:  Marike L Broekman; Sybren L N Maas; Erik R Abels; Thorsten R Mempel; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Rev Neurol       Date:  2018-08       Impact factor: 42.937

2.  Bivalent Inhibitor with Selectivity for Trimeric MMP-9 Amplifies Neutrophil Chemotaxis and Enables Functional Studies on MMP-9 Proteoforms.

Authors:  Elisa Nuti; Armando Rossello; Doretta Cuffaro; Caterina Camodeca; Jens Van Bael; Dries van der Maat; Erik Martens; Pierre Fiten; Rafaela Vaz Sousa Pereira; Estefania Ugarte-Berzal; Mieke Gouwy; Ghislain Opdenakker; Jennifer Vandooren
Journal:  Cells       Date:  2020-07-07       Impact factor: 6.600

3.  Discovery of Dimeric Arylsulfonamides as Potent ADAM8 Inhibitors.

Authors:  Doretta Cuffaro; Caterina Camodeca; Tiziano Tuccinardi; Lidia Ciccone; Jörg W Bartsch; Tanja Kellermann; Lena Cook; Elisa Nuti; Armando Rossello
Journal:  ACS Med Chem Lett       Date:  2021-10-08       Impact factor: 4.345

4.  Development of a fluorogenic ADAMTS-7 substrate.

Authors:  Salvatore Santamaria; Frederic Buemi; Elisa Nuti; Doretta Cuffaro; Elena De Vita; Tiziano Tuccinardi; Armando Rossello; Steven Howell; Shahid Mehmood; Ambrosius P Snijders; Rens de Groot
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.